RSV prevention and treatment in pediatric lung transplant patients: A survey of current practices among the International Pediatric Lung Transplant Collaborative

Pediatric Transplantation

Volumn 16, Issue 6, 2012, Pages 638-644

  Danziger Isakov, Lara A ^a   Arslan, Defne ^a   Sweet, Stuart ^b   Benden, Christian ^c   Goldfarb, Samuel ^d   Wong, Jackson ^e  

^a LERNER RESEARCH INSTITUTE   (United States)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

palivizumab; pediatric lung transplantation; Respiratory Syncytial Virus; ribavirin

Indexed keywords

IMMUNOGLOBULIN G; PALIVIZUMAB; RIBAVIRIN; STEROID;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL PRACTICE; DIAGNOSTIC PROCEDURE; HEALTH INSURANCE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INFANT; LUNG TRANSPLANTATION; PEDIATRIC SURGERY; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PROPHYLAXIS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INTERNATIONAL COOPERATION; LUNG DISEASES; LUNG TRANSPLANTATION; QUESTIONNAIRES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RIBAVIRIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864618997     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2012.01744.x     Document Type: Article

References (39)

1. Wright M, Piedimonte G,. Respiratory syncytial virus prevention and therapy: Past, present, and future. Pediatr Pulmonol 2011: 46: 324-347.
2. Wendt CH,. Community respiratory viruses: Organ transplant recipients. Am J Med 1997: 102: 31-36.;discussion 42-33.
3. Liu M, Mallory GB, Schecter MG, et al., Long-term impact of respiratory viral infection after pediatric lung transplantation. Pediatr Transplant 2010: 14: 431-436.
4. Liu M, Worley S, Arrigain S, et al., Respiratory viral infections within one year after pediatric lung transplant. Transpl Infect Dis 2009: 11: 304-312.
5. McCurdy LH, Milstone A, Dummer S,. Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin. J Heart Lung Transplant 2003: 22: 745-753. (Pubitemid 36842926)
6. Michaels MG, Fonseca-Aten M, Green M, et al., Respiratory syncytial virus prophylaxis: A survey of pediatric solid organ transplant centers. Pediatr Transplant 2009: 13: 451-456.
7. From the American Academy of Pediatrics: Policy statements-modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics 2009: 124: 1694-1701.
8. Uckay I, Gasche-Soccal PM, Kaiser L, et al., Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy. J Heart Lung Transplant 2010: 29: 299-305.
9. Pelaez A, Lyon GM, Force SD, et al., Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection. J Heart Lung Transplant 2009: 28: 67-71.
10. Glanville AR, Scott AI, Morton JM, et al., Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation. J Heart Lung Transplant 2005: 24: 2114-2119. (Pubitemid 41814734)
11. Liu V, Dhillon GS, Weill D,. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients. Transpl Infect Dis 2010: 12: 38-44.
12. Murris-Espin M, Didier A, Carre P, Icart J, Henry S, Leophonte P,. Continuous aerosolised tribavirin for respiratory syncytial virus infection in lung transplant recipients. Lancet 1993: 341: 897. (Pubitemid 23094543)
13. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG,. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009: 42: 377-381.
14. Zamora MR, Budev M, Rolfe M, et al., RNA interference therapy in lung transplant patients infected with respiratory syncytial virus. Am J Respir Crit Care Med 2011: 183: 531-538.
15. Milstone AP, Brumble LM, Barnes J, et al., A single-season prospective study of respiratory viral infections in lung transplant recipients. Eur Respir J 2006: 28: 131-137. (Pubitemid 44914270)
16. Kumar D, Erdman D, Keshavjee S, et al., Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 2005: 5: 2031-2036. (Pubitemid 41039882)
17. Khalifah AP, Hachem RR, Chakinala MM, et al., Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004: 170: 181-187. (Pubitemid 38925165)
18. Hopkins P, McNeil K, Kermeen F, et al., Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus. Am J Respir Crit Care Med 2008: 178: 876-881.
19. Gottlieb J, Schulz TF, Welte T, et al., Community-acquired respiratory viral infections in lung transplant recipients: A single season cohort study. Transplantation 2009: 87: 1530-1537.
20. Jansen RR, Wieringa J, Koekkoek SM, et al., Frequent detection of respiratory viruses without symptoms: Toward defining clinically relevant cutoff values. J Clin Microbiol 2011: 49: 2631-2636.
21. Harrington RD, Hooton TM, Hackman RC, et al., An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 1992: 165: 987-993.
22. Van Benten I, Koopman L, Niesters B, et al., Predominance of rhinovirus in the nose of symptomatic and asymptomatic infants. Pediatr Allergy Immunol 2003: 14: 363-370. (Pubitemid 37376969)
23. Adams R, Christenson J, Petersen F, Beatty P,. Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV. Bone Marrow Transplant 1999: 24: 661-664. (Pubitemid 29446142)
24. Whimbey E, Englund JA, Couch RB,. Community respiratory virus infections in immunocompromised patients with cancer. Am J Med 1997: 102: 10-18; discussion 25-26.
25. Nichols WG, Gooley T, Boeckh M,. Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: The Fred Hutchinson Cancer Research Center experience. Biol Blood Marrow Transplant 2001: 7 (Suppl): 11S-15S. (Pubitemid 33734763)
26. Nichols WG, Peck Campbell AJ, Boeckh M,. Respiratory viruses other than influenza virus: Impact and therapeutic advances. Clin Microbiol Rev 2008: 21: 274-290, table of contents. (Pubitemid 351555508)
27. Shah JN, Chemaly RF,. Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood 2011: 117: 2755-2763.
28. Flynn JD, Akers WS, Jones M, et al., Treatment of respiratory syncytial virus pneumonia in a lung transplant recipient: Case report and review of the literature. Pharmacotherapy 2004: 24: 932-938. (Pubitemid 38859143)
29. Doud JR, Hinkamp T, Garrity ER Jr,. Respiratory syncytial virus pneumonia in a lung transplant recipient: Case report. J Heart Lung Transplant 1992: 1: 77-79.
30. Weinberg A, Zamora MR, Li S, Torres F, Hodges TN,. The value of polymerase chain reaction for the diagnosis of viral respiratory tract infections in lung transplant recipients. J Clin Virol 2002: 25: 171-175. (Pubitemid 35287241)
31. Vu DL, Bridevaux PO, Aubert JD, Soccal PM, Kaiser L,. Respiratory viruses in lung transplant recipients: A critical review and pooled analysis of clinical studies. Am J Transplant 2011: 11: 1071-1078.
32. Billings JL, Hertz MI, Savik K, Wendt CH,. Respiratory viruses and chronic rejection in lung transplant recipients. J Heart Lung Transplant 2002: 21: 559-566. (Pubitemid 34451028)
33. Liu V, Dhillon GS, Weill D,. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients. Transpl Infect Dis 2010: 12: 38-44.
34. Chavez-Bueno S, Mejias A, Merryman RA, Ahmad N, Jafri HS, Ramilo O,. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Pediatr Infect Dis J 2007: 26: 1089-1093. (Pubitemid 350190938)
35. Frogel MP, Stewart DL, Hoopes M, Fernandes AW, Mahadevia PJ,. A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis. J Manag Care Pharm 2010: 16: 46-58.
36. Shults RA, Baron S, Decker J, Deitchman SD, Connor JD,. Health care worker exposure to aerosolized ribavirin: Biological and air monitoring. J Occup Environ Med 1996: 38: 257-263. (Pubitemid 26101178)
37. Linn WS, Gong H Jr, Anderson KR, Clark KW, Shamoo DA,. Exposures of health-care workers to ribavirin aerosol: A pharmacokinetic study. Arch Environ Health 1995: 50: 445-451.
38. Donnovan L, Fairest M, Graves L, et al., Guideline for administration of ribavirin, Final version 3. In: European Bone and Marrow Transplantation (UK) Nursing Group Conference; 2009. Available at
39. Ribavirin: Is there a risk to hospital personnel? Infectious Diseases and Immunization Committee, Canadian Paediatric Society. CMAJ 1991: 144: 285-286.